The "surprising way" is by using a derivate of LSD. I'd argue that the surprise is rather on this: "In clinical trials, a single dose significantly outperformed standard treatments, offering hope to those who have found little relief elsewhere."
> The "surprising way" is by using a derivate of LSD. What's the difference between a derivate and a derivative? (I'm not being facetious, I'd really rather like to know)
MM120, a pharmaceutical form of LSD, shown to reduce anxiety symptoms (2025)
31–40 of 108 posts
Re: MM120, a pharmaceutical form of LSD, shown to reduce anxiety symptoms (2025)
#32The "surprising way" is by using a derivate of LSD. I'd argue that the surprise is rather on this: "In clinical trials, a single dose significantly outperformed standard treatments, offering hope to those who have found little relief elsewhere."
Calling it the "pharmaceutical form" is borderline misinformation, considering it's just a common salt of LSD. You can get that outside the pharmacy. It's not like actual LSD is ever made in some dirty improv meth lab. Likewise, nobody expects researchers to buy their drugs on the streets. It's just LSD. This "say no to drugs" drug did the trick.
My understanding is that, today in the US (and other markets so far as I know), it is far easier to know a pharmacist than a genuine LSD chemist, though I am several years out of that particular market.
Would be nice to know there's been a resurgence of access to ergot via improvement in Claviceps growth or some nifty novel synthesis we didn't have a few years ago.
Re: MM120, a pharmaceutical form of LSD, shown to reduce anxiety symptoms (2025)
#33I'd argue that the results might not be from the drugs but from the fact that they were heavily monitored by other humans. It's not the drugs that people with high anxiety need, it's people giving them attention and caring for them. These experiments need a control where they just take the drug and they don't have medical staff around.
If only there were experts on the ground, designing the experiment, who could plan to avoid such interfering variables.
Re: MM120, a pharmaceutical form of LSD, shown to reduce anxiety symptoms (2025)
#341. Low volume cohort i.e. 40 participants per dose group
2. Industry sponsored study i.e. MindMed.
3. Think about it; how do you blind psychedelics? It's pretty obvious you're on one when you take it.
Re: MM120, a pharmaceutical form of LSD, shown to reduce anxiety symptoms (2025)
#35The "surprising way" is by using a derivate of LSD. I'd argue that the surprise is rather on this: "In clinical trials, a single dose significantly outperformed standard treatments, offering hope to those who have found little relief elsewhere."
Re: MM120, a pharmaceutical form of LSD, shown to reduce anxiety symptoms (2025)
#36It seems like every few weeks there's an article on how drugs are amazing hitting the front-page.
Yes, drugs are amazing.
Re: MM120, a pharmaceutical form of LSD, shown to reduce anxiety symptoms (2025)
#37The "surprising way" is by using a derivate of LSD. I'd argue that the surprise is rather on this: "In clinical trials, a single dose significantly outperformed standard treatments, offering hope to those who have found little relief elsewhere."
> The "surprising way" is by using a derivate of LSD. What's the difference between a derivate and a derivative? (I'm not being facetious, I'd really rather like to know)
Re: MM120, a pharmaceutical form of LSD, shown to reduce anxiety symptoms (2025)
#38Earlier quoted context omitted.
> The "surprising way" is by using a derivate of LSD. What's the difference between a derivate and a derivative? (I'm not being facetious, I'd really rather like to know)
Near as I can tell, they are essentially synonyms, but in practice "derivate" is "a product obtained chemically from a raw material", while "derivative" tends to be used in the mathematical or financial senses.
Maybe there's a word for this class of variations. Or variants?
Re: MM120, a pharmaceutical form of LSD, shown to reduce anxiety symptoms (2025)
#39Of course they want to repackage a cheaply synthesized substance at 100-1000x the costs even though the original likely works just as well. That's pharma for you.
Re: MM120, a pharmaceutical form of LSD, shown to reduce anxiety symptoms (2025)
#40The "surprising way" is by using a derivate of LSD. I'd argue that the surprise is rather on this: "In clinical trials, a single dose significantly outperformed standard treatments, offering hope to those who have found little relief elsewhere."